Brain reserve, brain maintenance and cognitive reserve: can these concepts aid in developing therapeutic interventions for ageing/Alzheimer's disease pathology?
Cognitive reserve and resilience
Professor Stern has been on the advisory board for Abbvie, Inc. He has also consulted for Lilly USA LLC, Takeda Pharmaceuticals USA Inc and Axovant Sciences, GmbH. Also, he has been a grant recipient from the California Walnut Commission, has an active license from Dependence Scale and Donation of tracer from Piramal Imaging Limited.